# Nexalin Technology, Inc. (NXL) — delisting/forced [announced]
Source: SEC API (secapi.ai) · situation sit_408103c142164b1613cf · retrieved 2026-08-11T16:13:58.235Z

## Overview
Nexalin Technology, Inc. manufactures electromedical and electrotherapeutic apparatus.

On July 24, 2026, Nasdaq notified Nexalin Technology, Inc. that the company's common stock failed to regain compliance with the Minimum Bid Price Requirement (minimum $1.00 per share) and does not meet the $5,000,000 minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq has scheduled the company's securities for delisting and suspension at the opening of business on August 4, 2026. The company may appeal this determination to a Nasdaq Hearings Panel by July 31, 2026, which would stay the suspension pending the panel's decision.

## Terms
- Counterparty: The Nasdaq Stock Market LLC

## Key dates
- Announced 2026-07-27 · Expiry 2026-07-31

## Timeline
- 2026-07-27 · 8-K (0001829126-26-007891): 8-K - Nexalin Technology, Inc. — *Nexalin Technology, Inc. manufactures electromedical and electrotherapeutic apparatus.* On July 24, 2026, Nasdaq notified Nexalin Technology, Inc. that the company's common stock failed to regain compliance with the Minimum Bid Price Requirement (minimum $1.00 per share) and does not meet the $5,000,000 minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq has scheduled the company's securities for delisting and suspension at the opening of business on August 4, 2026. The company may appeal this determination to a Nasdaq Hearings Panel by July 31, 2026, which would stay the suspension pending the panel's decision.
  https://www.sec.gov/Archives/edgar/data/1527352/0001829126-26-007891.txt

## Citations
- 0001829126-26-007891 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000182912626007891